Cargando…
Aneuploidy in targeted endoscopic biopsies outperforms other tissue biomarkers in the prediction of histologic progression of Barrett's oesophagus: A multi-centre prospective cohort study
BACKGROUND: The cancer risk in Barrett's oesophagus (BO) is difficult to estimate. Histologic dysplasia has strong predictive power, but can be missed by random biopsies. Other clinical parameters have limited utility for risk stratification. We aimed to assess whether a molecular biomarker pan...
Autores principales: | Hadjinicolaou, Andreas V., van Munster, Sanne N., Achilleos, Achilleas, Santiago Garcia, Jose, Killcoyne, Sarah, Ragunath, Krish, Bergman, Jacques J.G.H.M., Fitzgerald, Rebecca C., di Pietro, Massimiliano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251385/ https://www.ncbi.nlm.nih.gov/pubmed/32460165 http://dx.doi.org/10.1016/j.ebiom.2020.102765 |
Ejemplares similares
-
Management of Barrett's oesophagus
por: Mannath, Jayan, et al.
Publicado: (2009) -
Study to investigate the prevalence of human papillomavirus in Barrett’s oesophagus using a novel screening methodology
por: White, Jonathan Richard, et al.
Publicado: (2022) -
Barrett's oesophagus and adenocarcinoma
por: Caygill, Christine PJ, et al.
Publicado: (2004) -
The combination of autofluorescence endoscopy and molecular biomarkers is a novel diagnostic tool for dysplasia in Barrett's oesophagus
por: di Pietro, Massimiliano, et al.
Publicado: (2015) -
Real-world implementation of non-endoscopic triage testing for Barrett’s oesophagus during COVID-19
por: Landy, R, et al.
Publicado: (2023)